ESEF — Europäische Jahresabschlüsse (iXBRL) fact · reporting period
Ascelia Pharma AB: ifrs:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables
One fact, its scope and the complete path back to the official record.
Reported value
-1.362M{"amount": -1362000.0}- Entity
- Ascelia Pharma AB
- Metric
- ifrs:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables
- Period
- 2022-01-01 – 2022-12-31
- Status
- current
- Source
- ESEF — Europäische Jahresabschlüsse (iXBRL)
Provenance
Official reference
esef:5493002YR9VCJJPWYN08:2023-12-31Source licensePublic filings (ESEF-Verordnung)
Retrieved2026-08-23T23:58:32.725583+02:00
Raw response SHA-256
77955d91bfae34156c9ed34b7e96e25e…History
- no predecessors — first report
Why this page exists
The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.